Aurinia Pharmaceuticals (AUPH) Stock Price & Financial Analysis
Aurinia Pharmaceuticals Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Aurinia Pharmaceuticals
What is the current stock price for AUPH?
As of the latest trading session, AUPH stock trades at $16.46. The 52-week range is $7.29–$16.88, with a day range of $16.21–$16.50.
What is the P/E ratio for AUPH?
Aurinia Pharmaceuticals's trailing P/E ratio is 7.6, meaning investors pay $7.6 for every $1 of annual earnings. The forward P/E is 3.8, reflecting analyst expectations for future earnings. Aurinia Pharmaceuticals operates in the Healthcare sector.
Does AUPH pay dividends?
Aurinia Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for AUPH?
Based on 3 analysts, the consensus for AUPH is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of AUPH?
Aurinia Pharmaceuticals's market capitalization is $2.27B, classifying it as a mid-cap company. Aurinia Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.